These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3091978)

  • 1. Cost-effectiveness of introducing a third-generation test for HBsAg in Danish blood donors.
    Wantzin P; Skovgaard L; Tygstrup N; Nielsen JO; Soerensen H; Dybkjaer E
    Liver; 1986 Jun; 6(3):173-7. PubMed ID: 3091978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of Danish blood donors for hepatitis B surface antigen using a third generation technique.
    Wantzin P; Nielsen JO; Tygstrup N; Soerensen H; Dybkjaer E
    Br Med J (Clin Res Ed); 1985 Sep; 291(6498):780-2. PubMed ID: 3929937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of different methods of screening blood donations for HBsAg.
    Barbara JA; Howell DR; Cleghorn TE; Cameron CH; Briggs M; Dane DS
    Vox Sang; 1977; 32(1):4-9. PubMed ID: 841961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme-linked immunoassay for hepatitis B surface antigen. An evaluation of commercial test kits.
    Nath N; Dodd RY; Fang CT
    Transfusion; 1983; 23(1):45-8. PubMed ID: 6829058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved detection of hepatitis B surface antigen (HBsAg) in blood donors by monoclonal radioimmunoassay.
    Ben-Porath E; Wands JR; Bar-Shany S; Huggins C; Isselbacher K
    Transfusion; 1985; 25(1):10-4. PubMed ID: 3969695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cost-effectiveness analysis of screening for hepatitis B surface antigen in India.
    McNeil BJ; Dudley RA; Hoop B; Metz C; Thompson M; Adelstein SJ
    Med Decis Making; 1981; 1(4):345-59. PubMed ID: 6820460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and significance of anti-HBc in the blood bank; preliminary results of a controlled prospective study.
    Katchaki JN; Siem TH; Brouwer R; Brandt KH; van der Waart M
    J Virol Methods; 1980 Dec; 2(1-2):119-25. PubMed ID: 7228974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of radioimmunoassay and counterimmunoelectrophoresis for the detection of hepatitis B surface antigen carriers in a high-prevalence region.
    Sandler SG; Knecht A; Amar A; Davidowitch R
    Isr J Med Sci; 1979 Jul; 15(7):579-82. PubMed ID: 478821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for circulating immune complexes in blood donors as an effective method of further HBsAg carriers detection.
    Pintera J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(3):455-61. PubMed ID: 6169608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-transfusion hepatitis. Sudden drop of its incidence associated with hyperbilirubinemic donors disqualification.
    Pintera J; Krácmar C; Pinterová A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(3):415-25. PubMed ID: 2428716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health and economic impact of posttransfusion hepatitis B and cost-effectiveness analysis of expanded HBV testing protocols of blood donors: a study focused on the European Union.
    Pereira A
    Transfusion; 2003 Feb; 43(2):192-201. PubMed ID: 12559015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
    Busch MP
    Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of post-transfusion hepatitis. Role of sensitive hepatitis B antigen screening tests, source of blood and volume of transfusion.
    Koretz RL; Gitnick GL
    Am J Med; 1975 Dec; 59(6):754-60. PubMed ID: 1190252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of screening blood donors for antibody to hepatitis B core antigen.
    Archer AC; Cohen BJ; Mortimer PP
    J Clin Pathol; 1983 Aug; 36(8):924-8. PubMed ID: 6875019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of post-transfusion hepatitis. I. Evaluation of the effectiveness of donor selection by the test for HBsAg].
    Bondarenko MP; Stepanov GP
    Zh Mikrobiol Epidemiol Immunobiol; 1981 May; (5):44-8. PubMed ID: 7269917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly sensitive screening tests for hepatitis B surface antigen in transfusion centres of developing countries.
    Saha V; John TJ; Dhamodaran S; Carman RH
    BMJ; 1988 Jul; 297(6644):334-5. PubMed ID: 3137999
    [No Abstract]   [Full Text] [Related]  

  • 17. The emerging pattern of post-transfusion hepatitis.
    Alter HJ; Holland PV; Purcell RH
    Am J Med Sci; 1975; 270(2):329-34. PubMed ID: 1235474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HBsAg detection--results of comparative large scale testing of blood donations.
    Barr A; Dow BC; Macvarish I
    Med Lab Sci; 1979 Apr; 36(2):109-14. PubMed ID: 470559
    [No Abstract]   [Full Text] [Related]  

  • 19. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?
    Stramer SL; Zou S; Notari EP; Foster GA; Krysztof DE; Musavi F; Dodd RY
    Transfusion; 2012 Feb; 52(2):440-6. PubMed ID: 21810101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-donation screening of blood for transfusion transmissible infections: the gains and the pains - experience at a resource limited blood bank.
    Shittu AO; Olawumi HO; Adewuyi JO
    Ghana Med J; 2014 Sep; 48(3):158-62. PubMed ID: 25709126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.